FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768821520> ?p ?o ?g. }

• W2768821520 abstract "ABSTRACT Development of a vaccine to protect against cryptococcosis is a priority given the enormous global burden of disease in at-risk individuals. Using glucan particles (GPs) as a delivery system, we previously demonstrated that mice vaccinated with crude Cryptococcus -derived alkaline extracts were protected against lethal challenge with Cryptococcus neoformans and Cryptococcus gattii . The goal of the present study was to identify protective protein antigens that could be used in a subunit vaccine. Using biased and unbiased approaches, six candidate antigens (Cda1, Cda2, Cda3, Fpd1, MP88, and Sod1) were selected, recombinantly expressed in Escherichia coli , purified, and loaded into GPs. Three mouse strains (C57BL/6, BALB/c, and DR4) were then vaccinated with the antigen-laden GPs, following which they received a pulmonary challenge with virulent C. neoformans and C. gattii strains. Four candidate vaccines (GP-Cda1, GP-Cda2, GP-Cda3, and GP-Sod1) afforded a significant survival advantage in at least one mouse model; some vaccine combinations provided added protection over that seen with either antigen alone. Vaccine-mediated protection against C. neoformans did not necessarily predict protection against C. gattii . Vaccinated mice developed pulmonary inflammatory responses that effectively contained the infection; many surviving mice developed sterilizing immunity. Predicted T helper cell epitopes differed between mouse strains and in the degree to which they matched epitopes predicted in humans. Thus, we have discovered cryptococcal proteins that make promising candidate vaccine antigens. Protection varied depending on the mouse strain and cryptococcal species, suggesting that a successful human subunit vaccine will need to contain multiple antigens, including ones that are species specific. IMPORTANCE The encapsulated fungi Cryptococcus neoformans and Cryptococcus gattii are responsible for nearly 200,000 deaths annually, mostly in immunocompromised individuals. An effective vaccine could substantially reduce the burden of cryptococcosis. However, a major gap in cryptococcal vaccine development has been the discovery of protective antigens to use in vaccines. Here, six cryptococcal proteins with potential as vaccine antigens were expressed recombinantly and purified. Mice were then vaccinated with glucan particle preparations containing each antigen. Of the six candidate vaccines, four protected mice from a lethal cryptococcal challenge. However, the degree of protection varied as a function of mouse strain and cryptococcal species. These preclinical studies identify cryptococcal proteins that could serve as candidate vaccine antigens and provide a proof of principle regarding the feasibility of protein antigen-based vaccines to protect against cryptococcosis." @default.
• W2768821520 created "2017-12-04" @default.
• W2768821520 creator A5021951350 @default.
• W2768821520 creator A5032119933 @default.
• W2768821520 creator A5035268981 @default.
• W2768821520 creator A5041057598 @default.
• W2768821520 creator A5051081666 @default.
• W2768821520 creator A5054141043 @default.
• W2768821520 creator A5056742280 @default.
• W2768821520 creator A5057980496 @default.
• W2768821520 creator A5067212842 @default.
• W2768821520 creator A5069148985 @default.
• W2768821520 creator A5074345143 @default.
• W2768821520 creator A5076060876 @default.
• W2768821520 creator A5081023775 @default.
• W2768821520 creator A5081928892 @default.
• W2768821520 creator A5082676196 @default.
• W2768821520 creator A5091676156 @default.
• W2768821520 date "2017-12-29" @default.
• W2768821520 modified "2023-10-13" @default.
• W2768821520 title "Vaccination with Recombinant <i>Cryptococcus</i> Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species" @default.
• W2768821520 cites W1568922103 @default.
• W2768821520 cites W1938359025 @default.
• W2768821520 cites W1943178454 @default.
• W2768821520 cites W1965181237 @default.
• W2768821520 cites W1993548583 @default.
• W2768821520 cites W1994282287 @default.
• W2768821520 cites W1999361720 @default.
• W2768821520 cites W2005309617 @default.
• W2768821520 cites W2005361432 @default.
• W2768821520 cites W2017758723 @default.
• W2768821520 cites W2026004843 @default.
• W2768821520 cites W2048839273 @default.
• W2768821520 cites W2060646786 @default.
• W2768821520 cites W2062499819 @default.
• W2768821520 cites W2065557130 @default.
• W2768821520 cites W2070867977 @default.
• W2768821520 cites W2074184539 @default.
• W2768821520 cites W2081856420 @default.
• W2768821520 cites W2082580360 @default.
• W2768821520 cites W2089939918 @default.
• W2768821520 cites W2097568210 @default.
• W2768821520 cites W2098307337 @default.
• W2768821520 cites W2104096093 @default.
• W2768821520 cites W2106794673 @default.
• W2768821520 cites W2107794472 @default.
• W2768821520 cites W2108576174 @default.
• W2768821520 cites W2111314562 @default.
• W2768821520 cites W2112675507 @default.
• W2768821520 cites W2118442175 @default.
• W2768821520 cites W2119235066 @default.
• W2768821520 cites W2120277859 @default.
• W2768821520 cites W2132217769 @default.
• W2768821520 cites W2136981189 @default.
• W2768821520 cites W2138465665 @default.
• W2768821520 cites W2141210267 @default.
• W2768821520 cites W2147497666 @default.
• W2768821520 cites W2151255453 @default.
• W2768821520 cites W2153619807 @default.
• W2768821520 cites W2154503908 @default.
• W2768821520 cites W2160765050 @default.
• W2768821520 cites W2164390512 @default.
• W2768821520 cites W2168478752 @default.
• W2768821520 cites W2169908075 @default.
• W2768821520 cites W2170783157 @default.
• W2768821520 cites W2171349847 @default.
• W2768821520 cites W2192071399 @default.
• W2768821520 cites W2219979778 @default.
• W2768821520 cites W2357298441 @default.
• W2768821520 cites W2552182704 @default.
• W2768821520 cites W2611697423 @default.
• W2768821520 cites W4231689503 @default.
• W2768821520 doi "https://doi.org/10.1128/mbio.01872-17" @default.
• W2768821520 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5705919" @default.
• W2768821520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29184017" @default.
• W2768821520 hasPublicationYear "2017" @default.
• W2768821520 type Work @default.
• W2768821520 sameAs 2768821520 @default.
• W2768821520 citedByCount "62" @default.
• W2768821520 countsByYear W27688215202018 @default.
• W2768821520 countsByYear W27688215202019 @default.
• W2768821520 countsByYear W27688215202020 @default.
• W2768821520 countsByYear W27688215202021 @default.
• W2768821520 countsByYear W27688215202022 @default.
• W2768821520 countsByYear W27688215202023 @default.
• W2768821520 crossrefType "journal-article" @default.
• W2768821520 hasAuthorship W2768821520A5021951350 @default.
• W2768821520 hasAuthorship W2768821520A5032119933 @default.
• W2768821520 hasAuthorship W2768821520A5035268981 @default.
• W2768821520 hasAuthorship W2768821520A5041057598 @default.
• W2768821520 hasAuthorship W2768821520A5051081666 @default.
• W2768821520 hasAuthorship W2768821520A5054141043 @default.
• W2768821520 hasAuthorship W2768821520A5056742280 @default.
• W2768821520 hasAuthorship W2768821520A5057980496 @default.
• W2768821520 hasAuthorship W2768821520A5067212842 @default.
• W2768821520 hasAuthorship W2768821520A5069148985 @default.
• W2768821520 hasAuthorship W2768821520A5074345143 @default.
• W2768821520 hasAuthorship W2768821520A5076060876 @default.
• W2768821520 hasAuthorship W2768821520A5081023775 @default.
• W2768821520 hasAuthorship W2768821520A5081928892 @default.

• next